In patients whose TNM stage was III and IV, SOX11-positive group showed a trend of longer survival than SOX11-negative group, but not statistical significance ( Fig. 6A , left).
← all excerpts
The metastasis suppressor SOX11 is an independent prognostic factor for improved survival in gastric cancer.
1
—
—